{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:55:53Z","timestamp":1787021753966,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1006740","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000}}],"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["031A307"],"award-info":[{"award-number":["031A307"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1006740","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T13:33:28Z","timestamp":1548855208000},"page":"e1006740","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-6706","authenticated-orcid":true,"given":"Sulav","family":"Duwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5557-9396","authenticated-orcid":true,"given":"Laura","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-0967","authenticated-orcid":true,"given":"Saye","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6587-6394","authenticated-orcid":true,"given":"Max","family":"von Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"ref1","unstructured":"Grant R, Anderson P, McMahan V, Liu A, Amico K, Mehrotra M, et al. Results of the iPrEx open-label extension (iPrEx OLE) in men and transgender women who have sex with men: PrEP uptake, sexual practices, and HIV incidence. AIDS. 2014; p. 20\u201325."},{"issue":"10013","key":"ref2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"S McCormack","year":"2016","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"ref4","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1097\/QAD.0b013e32834d3cab","article-title":"The price of tenofovir-emtricitabine undermines the cost-effectiveness and advancement of pre-exposure prophylaxis","volume":"25","author":"SB Keller","year":"2011","journal-title":"AIDS"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1093\/cid\/ciu250","article-title":"Pharmacology lessons from chemoprophylaxis studies","volume":"59","author":"M Boffito","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref6","unstructured":"AIDS Vaccine Advocacy Coalition. Pre-Exposure Prophylaxis (PrEP) by the Numbers, (available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.avac.org\/sites\/default\/files\/resource-files\/prep_BTN_aug2016.pdf\" xlink:type=\"simple\">http:\/\/www.avac.org\/sites\/default\/files\/resource-files\/prep_BTN_aug2016.pdf<\/ext-link>, accessed 22-Oct- 2017.)."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1001401","DOI":"10.1371\/journal.pmed.1001401","article-title":"The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies","volume":"10","author":"GB Gomez","year":"2013","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/infdis\/jit150","article-title":"Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa","volume":"208","author":"UL Abbas","year":"2013","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/srep00185","article-title":"Modeling dynamic interactions between pre-exposure prophylaxis interventions &amp; treatment programs: predicting HIV transmission &amp; resistance","volume":"1","author":"V Supervie","year":"2011","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"12381","DOI":"10.1073\/pnas.1006061107","article-title":"HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis","volume":"107","author":"V Supervie","year":"2010","journal-title":"PNAS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e80927","DOI":"10.1371\/journal.pone.0080927","article-title":"Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness","volume":"8","author":"D Dimitrov","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2013.09.030","article-title":"Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design","volume":"155","author":"CW Hendrix","year":"2013","journal-title":"Cell"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1137\/120876800","article-title":"Stochastic analysis of pre- and postexposure prophylaxis against HIV infection","volume":"73","author":"JM Conway","year":"2013","journal-title":"SIAM J Appl Math"},{"issue":"1-2","key":"ref14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mbs.2008.03.005","article-title":"The probability of HIV infection in a new host and its reduction with microbicides","volume":"214","author":"HC Tuckwell","year":"2008","journal-title":"Math Biosci"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"e1001058","DOI":"10.1371\/journal.pcbi.1001058","article-title":"Stochastic theory of early viral infection: continuous versus burst production of virions","volume":"7","author":"JE Pearson","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00285-015-0961-5","article-title":"On the extinction probability in models of within-host infection: the role of latency and immunity","volume":"73","author":"AWC Yan","year":"2016","journal-title":"J Math Biol"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"e40382","DOI":"10.1371\/journal.pone.0040382","article-title":"Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection","volume":"7","author":"S Duwal","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/psp4.12095","article-title":"Multiscale Systems-Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV-1","volume":"5","author":"S Duwal","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"6193","key":"ref19","doi-asserted-by":"crossref","first-page":"1254031","DOI":"10.1126\/science.1254031","article-title":"HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck","volume":"345","author":"JM Carlson","year":"2014","journal-title":"Science"},{"issue":"15","key":"ref20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1056\/NEJM199704103361507","article-title":"Sexual transmission of HIV","volume":"336","author":"RA Royce","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1473-3099(09)70021-0","article-title":"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies","volume":"9","author":"MC Boily","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"21","key":"ref22","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"BF Keele","year":"2008","journal-title":"PNAS"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/JVI.02132-08","article-title":"Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants","volume":"83","author":"MR Abrahams","year":"2009","journal-title":"J Virol"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"e12303","DOI":"10.1371\/journal.pone.0012303","article-title":"Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing","volume":"5","author":"W Fischer","year":"2010","journal-title":"PloS one"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"e1000890","DOI":"10.1371\/journal.ppat.1000890","article-title":"High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men","volume":"6","author":"H Li","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref26","article-title":"An Introduction to Stochastic Processes with Applications to Biology","author":"LJS Allen","year":"2011"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"e1006155","DOI":"10.1371\/journal.pcbi.1006155","article-title":"Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes","volume":"14","author":"S Duwal","year":"2018","journal-title":"PLoS Comput. Biol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"e1000720","DOI":"10.1371\/journal.pcbi.1000720","article-title":"Drug-class specific impact of antivirals on the reproductive capacity of HIV","volume":"6","author":"M von Kleist","year":"2010","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"e18204","DOI":"10.1371\/journal.pone.0018204","article-title":"HIV Quasispecies Dynamics during Pro-active Treatment Switching: Impact on Multi-Drug Resistance and Resistance Archiving in Latent Reservoirs","volume":"6","author":"M von Kleist","year":"2011","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejps.2016.01.016","article-title":"Top-down and bottom-up modeling in system pharmacology to understand clinical efficacy: An example with NRTIs of HIV-1","volume":"94","author":"S Duwal","year":"2016","journal-title":"Eur J Pharm Sci"},{"issue":"16","key":"ref31","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1128\/JVI.00296-09","article-title":"Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization","volume":"83","author":"J Isaacman-Beck","year":"2009","journal-title":"J Virol"},{"issue":"13","key":"ref32","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1128\/JVI.03577-12","article-title":"Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design","volume":"87","author":"LH Ping","year":"2013","journal-title":"J Virol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0025-5564(97)00094-1","article-title":"Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies","volume":"147","author":"WY Tan","year":"1998","journal-title":"Math Biosci"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/jtbi.2000.1076","article-title":"Modeling plasma virus concentration during primary HIV infection","volume":"203","author":"MA Stafford","year":"2000","journal-title":"J Theor Biol"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling viral and immune system dynamics","volume":"2","author":"AS Perelson","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0025-5564(93)90043-A","article-title":"Dynamics of HIV infection of CD4+ T cells","volume":"114","author":"AS Perelson","year":"1993","journal-title":"Math Biosci"},{"issue":"17","key":"ref37","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1128\/JVI.76.17.8518-8513.2002","article-title":"Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection","volume":"76","author":"TC Pierson","year":"2002","journal-title":"J Virol"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/JVI.79.4.2199-2210.2005","article-title":"Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells","volume":"79","author":"Y Zhou","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"TC Chou","year":"2006","journal-title":"Pharmacolog Rev"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm1777","article-title":"Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs","volume":"14","author":"L Shen","year":"2008","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1098\/rsif.2005.0042","article-title":"Perspectives on the basic reproductive ratio","volume":"2","author":"JM Heffernan","year":"2005","journal-title":"J R Soc Interface"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrmicro3471","article-title":"Bottlenecks in HIV-1 transmission: insights from the study of founder viruses","volume":"13","author":"SB Joseph","year":"2015","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1473-3099(08)70156-7","article-title":"Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis","volume":"8","author":"KA Powers","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"ref44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group","volume":"342","author":"TC Quinn","year":"2000","journal-title":"N Engl J Med"},{"issue":"5265","key":"ref45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma","volume":"272","author":"JW Mellors","year":"1996","journal-title":"Science"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/QAI.0000000000001122","article-title":"Inferring HIV-1 Transmission Dynamics in Germany From Recently Transmitted Viruses","volume":"73","author":"KP Yousef","year":"2016","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9635","key":"ref47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(08)61115-0","article-title":"Relation between HIV viral load and infectiousness: a model-based analysis","volume":"372","author":"DP Wilson","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis","volume":"23","author":"S Attia","year":"2009","journal-title":"AIDS"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/jir747","article-title":"Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples","volume":"205","author":"JP Hughes","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"e1002359","DOI":"10.1371\/journal.pcbi.1002359","article-title":"HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection","volume":"8","author":"M von Kleist","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/S2352-3018(16)30113-8","article-title":"Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment","volume":"3","author":"I McGowan","year":"2016","journal-title":"Lancet HIV"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"L Van Damme","year":"2012","journal-title":"The New England journal of medicine"},{"key":"ref53","first-page":"238","article-title":"Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069\/ACTG A5305)","volume":"215","author":"RM Gulick","year":"2017","journal-title":"Journal Infect Dis"},{"key":"ref54","unstructured":"McGowan I, Nikiforov A, Young A, Cranston R, Landovitz RJ, Bakshi R, et al. PrEP Impact on T-Cell Activation and Explant Infection: HPTN 069\/ACTG 5305 Substudy. In: CROI2016, Boston. Oral presentation 104; 2016."},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/S2352-3018(17)30068-1","article-title":"Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial","volume":"4","author":"M Markowitz","year":"2017","journal-title":"Lancet HIV"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3851\/IMP1919","article-title":"Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract","volume":"16","author":"LJ Else","year":"2011","journal-title":"Antivir Ther"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/clpt.2011.99","article-title":"The male genital tract is not a pharmacological sanctuary from efavirenz","volume":"90","author":"LB Avery","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery","volume":"9","author":"DA Smith","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.bmcl.2013.02.070","article-title":"HCV versus HIV drug discovery: D\u00e9j\u00e0 vu all over again?","volume":"23","author":"WJ Watkins","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"ref60","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/088922203769232629","article-title":"Protein binding in antiretroviral therapies","volume":"19","author":"M Boffito","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10928-007-9071-3","article-title":"Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution","volume":"34","author":"M von Kleist","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/QAD.0b013e328359a978","article-title":"Measurement of plasma and intracellular concentrations of raltegravir in patients with HIV infection","volume":"26","author":"U Sandkovsky","year":"2012","journal-title":"AIDS"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1128\/AAC.00593-11","article-title":"Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteers","volume":"55","author":"L Wang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4-5","key":"ref64","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejps.2008.12.010","article-title":"Pharmacokinetic-pharmacodynamic relationship of NRTIs and its connection to viral escape: an example based on zidovudine","volume":"36","author":"M von Kleist","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"ref65","article-title":"A Translational Pharmacology Approach to Predicting HIV Pre-Exposure Prophylaxis Outcomes in Men and Women Using Tenofovir Disoproxil Fumarate +\/- Emtricitabine","author":"ML Cottrell","year":"2016","journal-title":"J Infect Dis"},{"issue":"7286","key":"ref66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature08757","article-title":"Targeting early infection to prevent HIV-1 mucosal transmission","volume":"464","author":"AT Haase","year":"2010","journal-title":"Nature"},{"issue":"7241","key":"ref67","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nature07831","article-title":"Glycerol monolaurate prevents mucosal SIV transmission","volume":"458","author":"Q Li","year":"2009","journal-title":"Nature"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"e1000274","DOI":"10.1371\/journal.ppat.1000274","article-title":"Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1","volume":"5","author":"RE Haaland","year":"2009","journal-title":"PLoS Pathog"},{"issue":"12","key":"ref69","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1128\/JVI.00127-10","article-title":"Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection","volume":"84","author":"RM Ribeiro","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"AJ McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"ref71","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1128\/AAC.00741-11","article-title":"Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes","volume":"55","author":"M Frank","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase","volume":"69","author":"LM Mansky","year":"1995","journal-title":"J Virol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/nm.2892","article-title":"Antiretroviral dynamics determines HIV evolution and predicts therapy outcome","volume":"18","author":"DIS Rosenbloom","year":"2012","journal-title":"Nat Med"},{"issue":"6","key":"ref75","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ni.3152","article-title":"HIV reservoirs as obstacles and opportunities for an HIV cure","volume":"16","author":"TW Chun","year":"2015","journal-title":"Nat Immunol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"JB Whitney","year":"2014","journal-title":"Nature"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","article-title":"Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection","volume":"95","author":"TW Chun","year":"1998","journal-title":"PNAS"},{"issue":"6510","key":"ref78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"X Wei","year":"1995","journal-title":"Nature"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/135965350901400212","article-title":"Constraints on the dominant mechanism for HIV viral dynamics in patients on raltegravir","volume":"14","author":"AR Sedaghat","year":"2009","journal-title":"Antivir Ther"},{"issue":"12","key":"ref80","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1073\/pnas.0711372105","article-title":"Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle","volume":"105","author":"AR Sedaghat","year":"2008","journal-title":"PNAS"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo","volume":"77","author":"M Markowitz","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"ref82","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1086\/525283","article-title":"Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro","volume":"197","author":"KK Koelsch","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jac\/dki308","article-title":"Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals","volume":"56","author":"LM Almond","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"ref84","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0009-9236(97)90133-8","article-title":"Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath test","volume":"61","author":"CL Cheng","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ref85","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/QAI.0b013e31825cb645","article-title":"Single and multiple dose pharmacokinetics of darunavir plus ritonavir and etravirine in semen and rectal tissue of HIV-negative men","volume":"61","author":"KC Brown","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref86","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/10895940-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of etravirine","volume":"48","author":"M Sch\u00f6ller-Gy\u00fcre","year":"2009","journal-title":"Clinical pharmacokinetics"},{"key":"ref87","unstructured":"Dickinson L, Bracchi M, Elliot E, Else L, Khoo S, Back D, et al. Population pharmacokinetics (PK) of dolutegravir (DTG) alone and following treatment switch. In: Journal of the International AIDS Society. vol. 19. INT AIDS SOCIETY AVENUE DE FRANCE 23, GENEVA, 1202, SWITZERLAND; 2016."},{"issue":"9","key":"ref88","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jcph.298","article-title":"Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations","volume":"54","author":"CA Delille","year":"2014","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"ref89","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/AAC.44.8.2173-2175.2000","article-title":"Indinavir population pharmacokinetics in plasma and cerebrospinal fluid","volume":"44","author":"SL Letendre","year":"2000","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"3","key":"ref90","first-page":"299","article-title":"Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir","volume":"29","author":"JW Holladay","year":"2001","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"ref91","first-page":"344","article-title":"Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals","volume":"27","author":"AI Veldkamp","year":"2001","journal-title":"JAIDS"},{"issue":"19","key":"ref92","doi-asserted-by":"crossref","first-page":"e90033","DOI":"10.1172\/jci.insight.90033","article-title":"Quantitative evaluation of the antiretroviral efficacy of dolutegravir","volume":"1","author":"SB Laskey","year":"2016","journal-title":"JCI Insight"},{"issue":"3","key":"ref93","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2649","article-title":"A quantitative basis for antiretroviral therapy for HIV-1 infection","volume":"18","author":"BL Jilek","year":"2012","journal-title":"Nat Med"},{"key":"ref94","unstructured":"Dickinson L, Bracchi M, Elliot E, Else L, Khoo S, Back D, et al. Population pharmacokinetics (PK) of dolutegravir (DTG) alone and following treatment switch. In: International Congress of Drug Therapy in HIV Infection, Glasgow, UK. Abstract P094; 2016."},{"issue":"2","key":"ref95","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcph.222","article-title":"The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers","volume":"54","author":"HM Crauwels","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1128\/AAC.01046-10","article-title":"Pharmacokinetic interactions of maraviroc with darunavir\/ritonavir, maraviroc with etravirine, and maraviroc with etravirine\/darunavir\/ritonavir in healthy volunteers: results of two drug interaction trials","volume":"55","author":"TN Kakuda","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1006740","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T00:31:33Z","timestamp":1662856293000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1006740"}},"subtitle":[],"editor":[{"given":"Sebastian","family":"Bonhoeffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1006740","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}